QNCX
Quince Therapeutics·NASDAQ
--
--(--)
--
--(--)
QNCX fundamentals
Quince Therapeutics (QNCX) released its earnings on Aug 11, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.34 (YoY +46.88%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.34
+46.88%
Report date
Aug 11, 2025
Earnings Call
4:00 PM on Aug 11, 2025
Meeting link.EPS
Actual | -0.61 | -0.6 | -0.73 | -0.72 | -0.51 | -0.64 | -0.13 | -0.28 | -0.34 | -0.34 | ||||||
Forecast | -0.4512 | -0.6186 | -0.6157 | -0.5476 | -0.2803 | -0.2876 | -0.1733 | -0.18 | -0.2275 | -0.2517 | ||||||
Surprise | 0.00% | 0.00% | -35.20% | +3.01% | -18.56% | -31.48% | -81.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +24.99% | -55.56% | -49.45% | -35.08% |
Revenue
Actual | -- | -- | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | -- | -- | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Quince Therapeutics's revenue and profit?What were the key takeaways from Quince Therapeutics's earnings call?What is the market's earnings forecast for Quince Therapeutics next quarter?What were the key takeaways from Quince Therapeutics’s earnings call?What guidance did Quince Therapeutics's management provide for the next earnings period?Did Quince Therapeutics beat or miss consensus estimates last quarter?What does Quince Therapeutics do and what are its main business segments?What is the revenue and EPS growth rate for Quince Therapeutics year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
